Correlation Between Cingulate Warrants and BriaCell Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and BriaCell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and BriaCell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cingulate Warrants and BriaCell Therapeutics Corp, you can compare the effects of market volatilities on Cingulate Warrants and BriaCell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of BriaCell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and BriaCell Therapeutics.

Diversification Opportunities for Cingulate Warrants and BriaCell Therapeutics

-0.4

Correlation Coefficient

Cingulate Warrants  BriaCell Therapeutics

Very good diversification

The 3 months correlation between Cingulate and BriaCell is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and BriaCell Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BriaCell Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with BriaCell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BriaCell Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and BriaCell Therapeutics go up and down completely randomly.

Pair Corralation between Cingulate Warrants and BriaCell Therapeutics

Assuming the 90 days horizon Cingulate Warrants is expected to generate 37.72 times less return on investment than BriaCell Therapeutics. In addition to that, Cingulate Warrants is 1.39 times more volatile than BriaCell Therapeutics Corp. It trades about 0.0 of its total potential returns per unit of risk. BriaCell Therapeutics Corp is currently generating about 0.21 per unit of volatility. If you would invest  18.00  in BriaCell Therapeutics Corp on September 12, 2024 and sell it today you would earn a total of  36.00  from holding BriaCell Therapeutics Corp or generate 200.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Cingulate Warrants  vs.  BriaCell Therapeutics Corp

Cingulate Warrants

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cingulate Warrants has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable technical and fundamental indicators, Cingulate Warrants is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

BriaCell Therapeutics

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in BriaCell Therapeutics Corp are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BriaCell Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cingulate Warrants and BriaCell Therapeutics

The main advantage of trading using opposite Cingulate Warrants and BriaCell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, BriaCell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BriaCell Therapeutics will offset losses from the drop in BriaCell Therapeutics' long position.

The idea behind Cingulate Warrants and BriaCell Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.